Transcutaneous Electrical Diaphragmatic Stimulation in PMV Patients

February 21, 2020 updated by: Chang Gung Memorial Hospital

Effects of Transcutaneous Electrical Diaphragmatic Stimulation on Respiratory Function in Patients With Prolonged Mechanical Ventilation

Muscle atrophy and diaphragm dysfunction are common with prolonged mechanical ventilation (PMV). Electrical stimulation has been shown to be beneficial in severe chronic heart failure and chronic obstructive pulmonary disease. However, its effect on PMV is unclear. This study examined the effects of transcutaneous electrical diaphragmatic stimulation (TEDS) on respiratory muscle strength and weaning outcomes in patients with PMV.

Study Overview

Status

Completed

Detailed Description

Patients on ventilation for ≥21 days were randomly assigned to TEDS and control groups. The TEDS group received muscle electrical stimulation for 30 min/session/day throughout the intervention. Weaning parameters (tidal volume, respiratory rate, and rapid shallow breathing index) and respiratory muscle strength (Pimax, Pemax) were assessed. The hospitalization outcome, including weaning rate and length of stay, was followed up until discharge.

Study Type

Interventional

Enrollment (Actual)

59

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Tao-Yuan
      • TaoYuan City, Tao-Yuan, Taiwan, 333
        • Chang Gung University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age ≥ 20 years;
  • MV for > 6 h/day for > 21 days;
  • Medical stability (PaO2 ≥ 60 mmHg at 40% FiO2, absence of signs and symptoms of infection, and hemodynamic stability).

Exclusion Criteria:

  • Acute lung or systemic infection, hemodynamic instability, patients with pacemakers, abdominal distention, and pregnancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: TEDS
Subjects received transcutaneous electrical diaphragm stimulation (TEDS) for 30min/ day till the end of the weaning trial
The electrodes were placed on the parasternal region beside the xiphoid process; and the sixth and seventh intercostal spaces in line with the mid-axillary line. TEDS was set as biphasic waves, frequency of 30 Hz, pulse width of 400 μs, and rise time of 0.7s.
No Intervention: Control
Subjects received similar medical treatment except for the TEDS program.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
tidal volume
Time Frame: 1st day of intervention
The tidal volume was measured by a spirometer
1st day of intervention
tidal volume
Time Frame: through study completion,an average of 4 weeks
The tidal volume was measured by a spirometer
through study completion,an average of 4 weeks
rapid shallow breathing index
Time Frame: 1st day of intervention
respiratory rate/tidal volume
1st day of intervention
rapid shallow breathing index
Time Frame: through study completion,an average of 4 weeks
respiratory rate/tidal volume
through study completion,an average of 4 weeks
respiratory muscle strength (maximal inspiratory pressure)
Time Frame: the 1st day of intervention
pressure gauge
the 1st day of intervention
respiratory muscle strength (maximal expiratory pressure)
Time Frame: the 1st day of intervention
pressure gauge
the 1st day of intervention
respiratory muscle strength (maximal inspiratory pressure)
Time Frame: through study completion,an average of 4 weeks
pressure gauge
through study completion,an average of 4 weeks
respiratory muscle strength (maximal expiratory pressure)
Time Frame: through study completion,an average of 4 weeks
pressure gauge
through study completion,an average of 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
weaning rate
Time Frame: through study completion,an average of 7 weeks
ventilator weaning results (weaning successful/failure)
through study completion,an average of 7 weeks
length of stay in respiratory care center
Time Frame: through study completion,an average of 7 weeks
the total days of stay in respiratory care center
through study completion,an average of 7 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yi-Fei Hsin, Chang Gung Memorial Hospital
  • Study Director: Yen-Huey Chen, Chang Gung University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 20, 2017

Primary Completion (Actual)

September 29, 2018

Study Completion (Actual)

July 25, 2019

Study Registration Dates

First Submitted

February 18, 2020

First Submitted That Met QC Criteria

February 21, 2020

First Posted (Actual)

February 24, 2020

Study Record Updates

Last Update Posted (Actual)

February 24, 2020

Last Update Submitted That Met QC Criteria

February 21, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 201700096A3D001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mechanical Ventilation

Clinical Trials on transcutaneous electric diaphragm stimulation

3
Subscribe